A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8+ T cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8+ T cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-28
DOI
10.1038/s41598-021-88676-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- (2020) Rita Cabrita et al. NATURE
- UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer
- (2020) Zijun Wang et al. Frontiers in Oncology
- Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy
- (2019) Tuba N. Gide et al. CANCER CELL
- Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy
- (2019) Elisabeth Perez-Ruiz et al. NATURE
- MIR155HG is a prognostic biomarker and associated with immune infiltration and immune checkpoint molecules expression in multiple cancers
- (2019) Lirong Peng et al. Cancer Medicine
- CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy
- (2019) Delong Liu Journal of Hematology & Oncology
- Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies
- (2019) Nikolaus B. Wagner et al. Journal for ImmunoTherapy of Cancer
- S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies
- (2018) Nikolaus B Wagner et al. BRITISH JOURNAL OF CANCER
- CD103+Tumor-Resident CD8+T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment
- (2018) Jarem Edwards et al. CLINICAL CANCER RESEARCH
- Inflammatory genes are novel prognostic biomarkers for colorectal cancer
- (2018) Hao Jiang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Lck promotes Zap70-dependent LAT phosphorylation by bridging Zap70 to LAT
- (2018) Wan-Lin Lo et al. NATURE IMMUNOLOGY
- Innate immune cell infiltration in melanoma metastases affects survival and is associated with BRAFV600E mutation status
- (2018) Nina Dabrosin et al. MELANOMA RESEARCH
- LinkedOmics: analyzing multi-omics data within and across 32 cancer types
- (2017) Suhas V Vasaikar et al. NUCLEIC ACIDS RESEARCH
- Serine Phosphorylation of SLP76 Is Dispensable for T Cell Development but Modulates Helper T Cell Function
- (2017) Victor H. Navas et al. PLoS One
- The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1
- (2017) Alexander Sankin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A putative molecular network associated with colon cancer metastasis constructed from microarray data
- (2017) Songtao Chu et al. World Journal of Surgical Oncology
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course
- (2016) N. Dezorella et al. HAEMATOLOGICA
- Development of nanoscale structure in LAT-based signaling complexes
- (2016) Valarie A. Barr et al. JOURNAL OF CELL SCIENCE
- SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course
- (2016) N. Dezorella et al. HAEMATOLOGICA
- The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer
- (2015) N. Antonio et al. EMBO JOURNAL
- Slp-76 is a critical determinant of NK-cell mediated recognition of missing-self targets
- (2015) Kristin Lampe et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Quantitative Reduction of the TCR Adapter Protein SLP-76 Unbalances Immunity and Immune Regulation
- (2015) Owen M. Siggs et al. JOURNAL OF IMMUNOLOGY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information
- (2014) Kaushala Jayawardana et al. INTERNATIONAL JOURNAL OF CANCER
- Proteomic Analysis of the SH2Domain-containing Leukocyte Protein of 76 kDa (SLP76) Interactome
- (2013) Yacine Bounab et al. MOLECULAR & CELLULAR PROTEOMICS
- Mislocalization of SLP-76 leads to aberrant inflammatory cytokine and autoantibody production
- (2009) G. F. Sonnenberg et al. BLOOD
- The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis
- (2008) Adam I Riker et al. BMC Medical Genomics
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started